Stoke Therapeutics (STOK) Cash & Equivalents (2018 - 2026)
Stoke Therapeutics (STOK) reported Cash & Equivalents of $107.27 million for Q3 2026, up 28.6% from $83.39 million a year earlier but down 2.5% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Stoke Therapeutics posted Cash & Equivalents of $84.22 million, down 34.2% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $127.98 million in FY2024 (-33.1%), $191.44 million in FY2023 (+68.6%), $113.56 million in FY2022 (-21.6%) and $144.9 million in FY2021 (-49.6%).
- Five-year quarterly Cash & Equivalents spans a low of $67.75 million in Q2 2022 and a high of $274.82 million in Q1 2025.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with an average decline of 14.0%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2023 (growth of 183.5%); the low point was Q1 2022 (a decline of 68.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $110 million (Q2 2026), $155.66 million (Q1 2026) and $84.22 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Stoke Therapeutics | 1.76 Bn | 523.36 Mn | - | 107.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 107.27 Mn |
| Jun 30, 2026 | 110.00 Mn |
| Mar 31, 2026 | 155.66 Mn |
| Dec 31, 2025 | 84.22 Mn |
| Sep 30, 2025 | 83.39 Mn |
| Jun 30, 2025 | 101.47 Mn |
| Mar 31, 2025 | 274.82 Mn |
| Dec 31, 2024 | 127.98 Mn |
| Sep 30, 2024 | 150.02 Mn |
| Jun 30, 2024 | 193.48 Mn |
| Mar 31, 2024 | 178.58 Mn |
| Dec 31, 2023 | 191.44 Mn |
| Sep 30, 2023 | 189.98 Mn |
| Jun 30, 2023 | 192.06 Mn |
| Mar 31, 2023 | 190.34 Mn |
| Dec 31, 2022 | 113.56 Mn |
| Sep 30, 2022 | 113.40 Mn |
| Jun 30, 2022 | 67.75 Mn |
| Mar 31, 2022 | 84.11 Mn |
| Dec 31, 2021 | 144.90 Mn |
API Access
Stoke Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();